Cargando…
Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer
BACKGROUND: The Insulin-like growth factor (IGF) pathway plays a role in tumour development and progression. In vivo, IGF1 activity is regulated by the IGF binding proteins (IGFBPs). IGFBP4 inhibits the activity of IGF1 but proteolytic cleavage by pregnancy-associated plasma protein-A (PAPP-A) relea...
Autores principales: | Smith, Y. E., Toomey, S., Napoletano, S., Kirwan, G., Schadow, C., Chubb, A. J., Mikkelsen, J. H., Oxvig, C., Harmey, J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196427/ https://www.ncbi.nlm.nih.gov/pubmed/30348128 http://dx.doi.org/10.1186/s12885-018-4950-0 |
Ejemplares similares
-
PAPP‐A: a promising therapeutic target for healthy longevity
por: Conover, Cheryl A., et al.
Publicado: (2016) -
Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity
por: Mikkelsen, Jakob H., et al.
Publicado: (2014) -
Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
por: Ryan, A J, et al.
Publicado: (2009) -
Structure of the PAPP-A(BP5) complex reveals mechanism of substrate recognition
por: Judge, Russell A., et al.
Publicado: (2022) -
Structure of the proteolytic enzyme PAPP-A with the endogenous inhibitor stanniocalcin-2 reveals its inhibitory mechanism
por: Kobberø, Sara Dam, et al.
Publicado: (2022)